Inner Mongolia Jingdong Pharmaceutical Co., Ltd. was established in late 2014 with a registered capital of 61.08 million yuan and a total planned project investment of 2.6 billion yuan. The company is dedicated to the research, development, and production of innovative drugs, first-to-market generic drugs, specialized active pharmaceutical ingredients (APIs), and high-tech pharmaceutical intermedi...